CERBA LANCET AFRICA COMPLETES STRATEGIC PARTNERSHIP WITH INTERNATIONAL CLINICAL LABORATORIES IN ETHIOPIA

Cerba Lancet Africa is majority owned by the French group Cerba HealthCare. Cerba HealthCare set foot on the African continent in 2019. It operates today in 15 countries under the Cerba Lancet Africa umbrella, providing access to accurate diagnosis and high-quality care to more almost 3 million people yearly.
International Clinical Laboratories (ICL) will leverage the world-class expertise range of Cerba HealthCare and its existing pan-African network Cerba Lancet Africa to meet the diagnostic tool expectations of patients, physicians, and hospitals nationwide. 
Joining the Cerba HealthCare family is one of ICL’s most outstanding achievements in terms of being able to expand our service and continue to provide quality tests to the population of Ethiopia and the surrounding region. It will allow us to tap into the vast resources and expertise of Cerba HealthCare, specifically in the fields of oncology, genetics, companion diagnostics, preventive medicine, patient and physician education, and research to tackle unique and challenging issues. This new foundation will allow us to expand our test menu and offer special services and tests that will contribute to the growth of the country’s healthcare system. We are excited about this strategic partnership and look forward to being part of the growing Cerba Lancet Africa network in the continent!